Sequence of Human Syndecan Indicates a Novel Gene Family of Integral Membrane Proteoglycans
Overview
Authors
Affiliations
The structure of human syndecan, an integral membrane proteoglycan, has been determined by cloning its full-length cDNA, which codes for the entire 310-amino acid-long core protein, including the NH2-terminal signal peptide. Similar to mouse syndecan (Saunders, S., Jalkanen, M., O'Farrell, S., and Bernfield, M. (1989) J. Cell Biol. 108, 1547-1556), the core protein of human syndecan can be divided into three domains: a matrix-interacting ectodomain containing putative glycosaminoglycan attachment sites, a 25-residue hydrophobic membrane-spanning domain, and a 34-residue cytoplasmic domain. Several interesting conserved structures were revealed by comparing the human syndecan sequence to the murine one. (i) Although the ectodomains are only 70% identical, all putative glycosaminoglycan attachment sites are identical (two of them belong to the consensus sequence SGXG and three others to (E/D)GSG(E/D), as are also (ii) the single putative N-glycosylation site and (iii) the proteinase-sensitive dibasic RK site adjacent to the extracellular face of the transmembrane domain. Furthermore, (iv) the transmembrane domain is 96% identical, as the only change in human syndecan was an alteration of an alanine residue to glycine; and finally, (v) the cytoplasmic domain is 100% identical, including 3 identically located tyrosine residues. Comparison of transmembrane and cytoplasmic domains to a third cell-surface proteoglycan, 48K5 from human lung fibroblasts (Marynen, P., Zhang, J., Cassiman, J., Vanden Berghe, H., and David, C. (1989) J. Biol. Chem. 264, 7017-7024), indicates that the transmembrane and cytoplasmic domains are similar also in this molecule regardless of the presence of a totally nonhomologous ectodomain. Thus, the transmembrane and cytoplasmic domains are unique for these cell-surface proteoglycans, which we propose to be members of a novel gene family of syndecans.
Zeng L, Zheng W, Liu X, Zhou Y, Jin X, Xiao Y Theranostics. 2023; 13(11):3725-3743.
PMID: 37441590 PMC: 10334832. DOI: 10.7150/thno.81999.
Biodistribution and Cellular Internalization of Inactivated SARS-CoV-2 in Wild-Type Mice.
Hudak A, Morgan G, Bacovsky J, Patai R, Polgar T, Letoha A Int J Mol Sci. 2022; 23(14).
PMID: 35886958 PMC: 9316427. DOI: 10.3390/ijms23147609.
Targeting syndecan-1: new opportunities in cancer therapy.
Yang Z, Chen S, Ying H, Yao W Am J Physiol Cell Physiol. 2022; 323(1):C29-C45.
PMID: 35584326 PMC: 9236862. DOI: 10.1152/ajpcell.00024.2022.
Li T, Yang W, Ramadan S, Huang X Org Lett. 2020; 22(16):6429-6433.
PMID: 32806172 PMC: 7517924. DOI: 10.1021/acs.orglett.0c02243.
Asega A, Menezes M, Trevisan-Silva D, Cajado-Carvalho D, Bertholim L, Oliveira A Sci Rep. 2020; 10(1):12912.
PMID: 32737331 PMC: 7395112. DOI: 10.1038/s41598-020-69396-y.